SCHEMBL2255686

SCHEMBL2255686

O=C(O)c1ccc(-c2ccc(F)cc2)cc1/C=C/c1ccc(/C=C/c2ccccc2)cc1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.85
BAD Q92934 1/20 0.85
NFE2L2 Q16236 4/20 0.51
HNF4A P41235 2/20 0.48
PTPN1 P18031 2/20 0.48
TRPM2 O94759 1/20 0.47
SNCA P37840 2/20 0.46
TRPA1 O75762 1/20 0.46
ACMSD Q8TDX5 1/20 0.44
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
KMT2A Q03164 1/20 0.43
PTPN6 P29350 1/20 0.43
DHODH Q02127 1/20 0.43
MAOB P27338 1/20 0.43
GRIK1 P39086 1/20 0.42
GRIA1 P42261 1/20 0.42
GRIA2 P42262 1/20 0.42
GRIA3 P42263 1/20 0.42
GRIA4 P48058 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2255687 1.00 BCL2L1 (0.85) BCL2L1BADNFE2L2HNF4APTPN1
SCHEMBL2256914 0.97 BCL2L1 (0.85) BCL2L1BADNFE2L2HNF4APTPN1
SCHEMBL2256911 0.97 BCL2L1 (0.85) BCL2L1BADNFE2L2HNF4APTPN1
SCHEMBL2254360 0.96 BCL2L1 (0.77) BCL2L1BADNFE2L2HNF4APTPN1
SCHEMBL2254358 0.96 BCL2L1 (0.77) BCL2L1BADNFE2L2HNF4APTPN1
SCHEMBL2253708 0.92 BCL2L1 (1.00) BCL2L1BADNFE2L2HNF4APTPN1
SCHEMBL2253706 0.92 BCL2L1 (1.00) BCL2L1BADNFE2L2HNF4APTPN1
SCHEMBL2254647 0.90 BCL2L1 (0.70) BCL2L1BADNFE2L2PTPN1TRPM2
SCHEMBL2254645 0.90 BCL2L1 (0.70) BCL2L1BADNFE2L2PTPN1TRPM2
SCHEMBL2253045 0.90 BCL2L1 (0.70) BCL2L1BADTRPM2SNCATRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904047-B1 APOPTOSIS PROMOTERS ABBOTT LAB (US) 2013-01-02 EP disclosed
US-7989656-B2 Biaryl carboxylic acid apoptosis promoters ABBOTT LABORATORIES (US) 2011-08-02 US disclosed
US-20100234456-A1 APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2010-09-16 US disclosed
US-7750004-B2 Apoptosis promoters ABBOTT LABORATORIES (US) 2010-07-06 US disclosed
US-20070135392-A1 Apoptosis promoters ABBVIE INC. 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234456-A1 APOPTOSIS PROMOTERS MCL1, BAX, BCL2 BCL2L1 5/4885BAD 11/4885NFE2L2 272/4885
US-20070135392-A1 Apoptosis promoters MCL1, BAX, BCL2 BCL2L1 5/4885BAD 11/4885NFE2L2 272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.